FDA Inspection 1252580 — Jeffrey T. Apter, M.D.
The FDA completed an inspection of Jeffrey T. Apter, M.D. on October 22, 2024 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Princeton, NJ (United States)
Additional Details
Clinical Investigator (CI)